Physician profile
Ashlee Brown
NPI 1083478903
$343.88
in general payments reported to CMS, 2019-2025
10 companies · $86.86 in 2025
The $86.86 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $257 · 2025: $86.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $344.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $343.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $101.98 | 2024 | Azstarys |
| Noven Therapeutics, LLC | $76.73 | 2024 | Xelstrym |
| Collegium Pharmaceutical, INC. | $36.41 | 2025 | Jornay Pm |
| Baxter Healthcare | $28.25 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Seqirus USA INC | $22.04 | 2025 | Flucelvax |
| Kaleo, INC. | $20.83 | 2024 | Auvi-Q |
| Merck Sharp & Dohme LLC | $15.82 | 2024 | Proquad, Vaxneuvance, Gardasil 9 |
| Sanofi Pasteur INC. | $14.37 | 2025 | |
| Pfizer INC. | $14.04 | 2025 | |
| Biomarin Pharmaceutical INC. | $13.41 | 2024 | Voxzogo 1.2mg |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashlee Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.